Table 5.
Drug sensitivity test results of the HY9901 and HY9901ΔtyeA.
| Antibiotic | Dose (μg) | Bacteriostatic circle diameter (mm) | |||
|---|---|---|---|---|---|
| HY9901 | Sensitivity | ΔtyeA | Sensitivity | ||
| Cefperazone | 75 | 0 | R | 0 | R |
| Oxacillin | 1 | 0 | R | 0 | R |
| Clindamycin | 2 | 0 | R | 0 | R |
| Ceftazidime | 30 | 0 | R | 0 | R |
| Penicillin | 10U | 0 | R | 0 | R |
| Ampicillin | 100 | 0 | R | 0 | R |
| Caebenicillin | 100 | 0 | R | 0 | R |
| Cefazolin | 30 | 8.0 ± 0.2 | R | 0 | R |
| Ceftriaxone | 30 | 9.3 ± 0.3 | R | 0 | R |
| Cephradine | 30 | 0 | R | 0 | R |
| Piperacillin | 100 | 0 | R | 0 | R |
| Cefuroxime | 30 | 0 | R | 0 | R |
| SMZ/TMP | 23.75/1.25 | 0 | R | 0 | R |
| Aboren | 30 | 0 | R | 0 | R |
| Vancomycin | 30 | 0 | R | 0 | R |
| Cephalexin | 30 | 0 | R | 0 | R |
| polymxinB | 200IU | 0 | R | 0 | R |
| Norfloxacin | 10 | 0 | R | 0 | R |
| Ofloxacin | 5 | 0 | R | 0 | R |
| Ciprofloxacin | 5 | 0 | R | 0 | R |
| Amikacin | 30 | 13.3 ± 0.3 | I | 10.0 ± 0.1 | I |
| Minocyline | 30 | 18.5 ± 0.2 | S | 14.3 ± 0.3 | I |
| Tetracyline | 30 | 13.5 ± 0.2 | I | 12.5 ± 0.2 | R |
| Gentamicin | 10 | 14.5 ± 0.1 | I | 12.5 ± 0.2 | I |
| Furazolidone | 300 | 10.5 ± 0.4 | R | 8.0 ± 0.1 | R |
| Chloramphenicol | 30 | 17.2 ± 0.3 | S | 0 | R |
| kanamycin | 30 | 14.1 ± 0.2 | I | 12.1 ± 0.2 | R |
| Erythromycin | 15 | 10.1 ± 0.2 | R | 0 | R |
| Doxycycline | 30 | 16.5 ± 0.3 | S | 10.6 ± 0.1 | R |
| Cefperazone | 30 | 14.2 ± 0.3 | I | 13.3 ± 0.3 | I |
S(susceptible) I(intermediate) R(resistance).